MUMBAI (MarketWatch) -- India’s Aurobindo Pharma Ltd. (524804.BY) said Monday it has received a tentative approval from the U.S. Food & Drug Administration for simvastatin, a medicine used to lower the level of cholesterol. The tentative approval is for 5 milligram, 10 mg, 20 mg, 40 mg and 80 mg tablets, said Aurobindo in a notice to the stock exchange.
